Dudum Amends Hims & Hers 13D Filing
Ticker: HIMS · Form: SC 13D/A · Filed: 2024-10-25T00:00:00.000Z
Sentiment: neutral
Topics: sec-filing, schedule-13d, ownership-update
Related Tickers: HIMS
TL;DR
Andrew Dudum updated his Hims & Hers stake filing on 10/25/24, event date 03/01/24.
AI Summary
Andrew Dudum filed an amendment (No. 2) to his Schedule 13D on October 25, 2024, regarding his holdings in Hims & Hers Health, Inc. The filing indicates a change in the date of the event requiring this statement to March 1, 2024. Dudum's address is listed as 2269 Chestnut Street, #523, San Francisco, CA.
Why It Matters
This amendment updates the filing for significant beneficial ownership of Hims & Hers Health, Inc., providing transparency to investors about changes in holdings.
Risk Assessment
Risk Level: low — This is a routine amendment to a Schedule 13D filing, not indicating new material events or significant shifts in ownership.
Key Numbers
- 2 — Amendment Number (Indicates this is the second amendment to the original filing.)
Key Players & Entities
- Andrew Dudum (person) — Filing person and beneficial owner
- Hims & Hers Health, Inc. (company) — Subject company
- Oaktree Acquisition Corp. (company) — Former company name
FAQ
What is the purpose of this SC 13D/A filing?
This filing is an amendment (No. 2) to a Schedule 13D, used to report changes in beneficial ownership of a public company's securities.
Who is the filing person?
The filing person is Andrew Dudum.
What company is the subject of this filing?
The subject company is Hims & Hers Health, Inc.
When was the event that requires this filing?
The date of the event which requires filing of this statement is March 1, 2024.
What was the former name of Hims & Hers Health, Inc.?
The former company name was Oaktree Acquisition Corp., with a date of name change on April 12, 2019.
From the Filing
0001193125-24-244170.txt : 20241025 0001193125-24-244170.hdr.sgml : 20241025 20241025163456 ACCESSION NUMBER: 0001193125-24-244170 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20241025 DATE AS OF CHANGE: 20241025 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Hims & Hers Health, Inc. CENTRAL INDEX KEY: 0001773751 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-91087 FILM NUMBER: 241397473 BUSINESS ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 BUSINESS PHONE: 415-851-0195 MAIL ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 FORMER COMPANY: FORMER CONFORMED NAME: Oaktree Acquisition Corp. DATE OF NAME CHANGE: 20190412 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Dudum Andrew CENTRAL INDEX KEY: 0001837796 ORGANIZATION NAME: FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: 2269 CHESTNUT STREET, #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 SC 13D/A 1 d898514dsc13da.htm SC 13D/A SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Hims & Hers Health, Inc. (Name of Issuer) Class A Common Stock, $0.0001 par value (Title of Class of Securities) 433000 106 (CUSIP Number) Andrew Dudum 2269 Chestnut Street, #523 San Francisco, California 94123 (415) 851-0195 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) March 1, 2024 (Date of Event Which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box: ☐ Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 433000 106 SCHEDULE 13D Page 1 of 3  1.    Names of Reporting Persons.  Andrew Dudum  2.  Check the Appropriate Box if a Member of a Group (See Instructions)  (a) ☐  (b) ☐  3.  SEC Use Only  4.  Source of Funds (See Instructions)  SC, PF  5.  Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)  ☐  6.  Citizenship or Place of Organization  United States Number of Shares Beneficially  Owned by Each Reporting Person With  7.    Sole Voting Power  24,621,321 (1)(2)  8.  Shared Voting Power  0  9.  Sole Dispositive Power  24,621,321 (1)(2) 10.  Shared Dispositive Power  0 11.    Aggregate Amount Beneficially Owned by Each Reporting Person  24,621,321 12.  Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)  ☐ 13.